Current Fellows' Research & Clinical Interests
(Preceptor and Preceptor’s Department or Division)
Gregory Behbehani, MD, PhD
Second-year fellow; will begin research in January 2010
Millie Das, MD
Second-year fellow; will begin research in January 2010
Monique de Bruin, MD, MPH
First-year fellow; will begin research in January 2011
Tamara Dunn, MD
First-year fellow; will begin research in January 2011
Basem Goueli, MD, PhD
Second-year fellow; will begin research in January 2010
Matt Gubens, MD, MS
Second-year fellow; will begin research in August 2009
Gregory Heestand, MD (George Fisher, Oncology)
Signaling pathways in pancreatic cancer
Wan-Jen Hong, MD
First-year fellow; will begin research in January 2011
Jerry Hsu, MD, PhD (Steve Artandi, Hematology)
Role of telomerase in cancer development
Brian Jonas, MD, PhD
First-year fellow; will begin research in January 2011
Susan Kao, MD (Jason Gotlib, Hematology)
Clinical trials in bone marrow failure
Holbrook Kohrt, MD (Ronald Levy, Oncology; Samuel Strober, Immunology)
Combination antibody therapy in lymphoma
Atul Kumar, MD, PhD (Allan Ballmain, Cancer Research Institute, UCSF)
Role of Lung Stem Cells in Adenocarcinomas
Aaron Logan, MD, PhD
Second year fellow, clinical BMT; will begin research in January 2010
Lauren Maeda, MD
Second-year fellow; will begin research in January 2010
James (Scott) McClellan, MD, PhD
Second-year fellow; will begin research in January 2010
Amy McMullen, MD (George Fisher and Jim Ford, Oncology; Albert Koong, Radiation Oncology)
Clinical trials in pancreatic cancer
Mehrdad Mobasher, MD (George Fisher, Oncology)
Epidemiology and clinical trials in GI oncology/colorectal cancers
Lincoln Nadauld, MD, PhD
First-year fellow; will begin research in July 2010
Marie Nguyen, MD
First-year fellow; will begin research in January 2011
Stephen Oh, MD, PhD (Garry Nolan, Microbiology and Immunology)
Signaling in AML
Stavroula (Stevie) Otis, MD (Jim Zehnder, Hematology)
Transitioning from argatrobin to warfarin in patient with HIT
Manali Patel, MD
First-year fellow; will begin research in January 2011
Priti Patel, MD/MS
Second-year fellow; will begin research in August 2009
Daniel Pollyea, MD (Beverly Mitchell and Bruno Medeiros, Hematology)
Rational treatment strategies for elderly, previously untreated patients with acute myeloid leukemia (AML)
Jonathan Riess, MD
First-year fellow; will begin research in January 2011
Mahesh Seetharam, MD (Peter Greenberg, Hematology)
Clinical trials in MDS
Shaveta Vinayak, MD (James Ford and Allison Kurian, Oncology)
Translational research in breast cancer
Wesley Witteles, MD (Jason Gotlib, Hematology)
Clinical trials in myeloproliferative disorders
Jennifer Young, MD
Second-year fellow; will begin research in January 2010
Instructors' Research & Clinical Interests
Arash (Ash) Alizadeh MD, PhD (Ronald Levy, Oncology)
Stem cells in hematologic diseases
Joshua Brody, MD (Ronald Levy, Oncology)
Immunotherapy of lymphoma, specifically model systems and clinical trials of dendritic cell vaccines.
Alice Fan, MD (Dean Felsher, Oncology)
Translational studies to validate the activity of targeted therapies using novel nanoscale technologies. Applying nanoscale proteomic analysis to clinical study of atorvastatin for lymphoma.
Lauren Harshman, MD (Sandy Srinivas, Oncology)
Clinical Trials in GU Oncology
Eric Humke, MD, PhD (Matt Scott, Developmental Biology)
WNT pathway as signaling in lung and pancreas cancers
Pamela L. Kunz, MD (George Fisher and James Ford, Oncology )
Gastrointestinal clinical research
Elizabeth Price, MD (Stan Schrier, Hematology)
Anemia in the elderly study
Melinda Telli, MD (Ellie Guardino and Robert Carlson, Oncology)
Clinical trials in breast oncology
Yu Wong, MD, PhD (Mark Davis, Microbiology and Immunology)
Design of novel approach to measure T cell repertoire. Translational research in breast cancer.